Repositioning Candidate Details
| Candidate ID: | R0521 |
| Source ID: | DB12665 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | Isoquercetin |
| Synonyms: | |
| Molecular Formula: | C21H20O12 |
| SMILES: | OC[C@H]1O[C@@H](OC2=C(OC3=C(C(O)=CC(O)=C3)C2=O)C2=CC=C(O)C(O)=C2)[C@H](O)[C@@H](O)[C@@H]1O |
| Structure: |
|
| DrugBank Description: | Isoquercetin has been used in trials studying the treatment of Kidney Cancer, Renal cell carcinoma, Advanced Renal Cell Carcinoma, Thromboembolism of Vein in Pancreatic Cancer, and Thromboembolism of Vein VTE in Colorectal Cancer, among others. |
| CAS Number: | 482-35-9 |
| Molecular Weight: | 464.3763 |
| DrugBank Indication: | |
| DrugBank Pharmacology: | |
| DrugBank MoA: | |
| Targets: | |
| Inclusion Criteria: |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class |
|---|